A gut feeling about plasmablasts

Research output: Contribution to journalComment / DebateOtherpeer-review

Abstract

Detailed characterization of the plasma cell precursors that persist in patients' blood after rituximab treatment suggests a mucosal origin, potentially identifying a subset of B cells refractory to anti-CD20 depletion and capable of continued differentiation.

Original languageEnglish
Pages (from-to)5083-5084
Number of pages2
JournalBlood
Volume116
Issue number24
DOIs
Publication statusPublished - 9 Dec 2010
Externally publishedYes

Cite this